✦ LIBER ✦

PDB34 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF A MODERN INSULIN IN PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES IN THE GERMAN SETTING; DATA FROMTHE PREDICTIVE STUDY

✍ Scribed by JL Palmer; G Goodall; M Aagren; S Nielsen; R Kotchie; WJ Valentine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB20 COST EFFECTIVENESS ANALYSIS OF SWI

✍ T Doležal; Z Písaríková; K Rychna; M Honka; D Bartášková 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PDB30 A MODELLED COST-EFFECTIVENESS ANAL

✍ L Stechemesser; R Weitgasser; M Hofmann; M Aagren; R Mihaljev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PDB24 LONG-TERM CLINICAL AND COST OUTCOM

✍ JP Clegg; WJ Valentine; K Rychna; M Honka; T Dolezal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Long-term tolerability of inhaled human

✍ A. H. Barnett; P. Lange; M. Dreyer; M. Serdarevic-Pehar; on behalf of the Exuber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

PDB33 EVALUATING THE COST-EFFECTIVENESS

✍ L. Yang; A.L. Lay; J.H. Chang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB